https://www.selleckchem.com/pr....oducts/gsk1016790a.h
Hemorrhagic events such as SSEH should be considered during treatment with angiogenesis inhibitors.A male patient in his 70s underwent a right lobectomy because of a hepatocellular carcinoma(HCC)located in the right lobe(S6)of his liver. Eleven months after surgery, contrast-enhanced CT showed multiple masses in the residual liver, which were diagnosed as HCC recurrence. He was then treated with hepatic arterial infusion chemotherapy(HAIC). Ten months after the recurrence, the liver tumors progressed. Therefore, treatment was switch
Like
Comment
Share
